MedTrace Logo

Early External Cephalic Version (ECV) 2 Trial

NCT00141687 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1543

Last updated 2016-09-15

No results posted yet for this study

Summary

For women with a fetus in breech presentation, does early ECV (at 34 0/7 up to 35 weeks and 6/7 days) versus delayed ECV (not before 37 weeks and 0/7 days) increase or decrease the likelihood of cesarean section (CS)?

Conditions

  • Breech Presentation

Interventions

PROCEDURE

Early ECV between 34 0/7 and 35 6/7 weeks

Early external cephalic version between 34 0/7 and 35 6/7 weeks of gestation

PROCEDURE

Delayed ECV at or after 37 0/7 weeks

Delayed external cephalic version at or after 37 0/7 weeks of gestation

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • University of British Columbia

    collaborator OTHER

  • McMaster University

    lead OTHER

Principal Investigators

  • Dr. Eileen Hutton, PhD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00141687 on ClinicalTrials.gov